The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: FTSE 100 seen flat; Just Eat and Sainsbury's partner

Mon, 16th Jan 2023 07:50

(Alliance News) - With US financial markets closed for a public holiday on Monday and after better-than-expected data for the UK economy on Friday, stocks in London were set to start the week slightly higher.

UK gross domestic product grew by 0.1% month-on-month in November, slowing from October's unrevised growth of 0.5%. The economy defied expectations which anticipated it to shrink by 0.2% in November, according to consensus cited by FXStreet.

GDP was helped by the start of the football World Cup, which boosted consumer-facing sectors, the Office for National Statistics explained.

In further signs of emerging stability for the UK economy, the average asking price for a house in the UK rose in January, according to the data from Rightmove on Monday.

The average price of a property coming to the market for sale rose to GBP362,438 in January, up 0.9% from GBP359,137 in December. Rightmove said this was the biggest increase at this time of year since 2020.

"After the market's uncertain final few months of 2022, this familiar seasonality is a tentative sign of stability...It's still early days, but this is a more encouraging start to the year than many anticipated," Rightmove said.

In UK company news, ITM Power issued a warning on its full-year results, while AstraZeneca completed its acquisition of clinical-stage biotechnology company Neogene Therapeutics.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called flat at 7,844.00

----------

Hang Seng: down 0.2% at 21,706.14

Nikkei 225: closed down 1.1% at 25,822.32

S&P/ASX 200: closed up 0.8% at 7,388.20

----------

DJIA: closed up 112.64 points, or 0.3%, at 34,302.61

S&P 500: closed up 15.92 points, or 0.4%, at 3,999.09

Nasdaq Composite: closed up 78.05 points, or 0.7%, at 4,000.70

----------

EUR: higher at USD1.0835 (USD1.0820)

GBP: higher at USD1.2230 (USD1.2209)

USD: higher at JPY128.10 (JPY127.85)

Gold: higher at USD1,916.75 per ounce (USD1,911.40)

(Brent): lower at USD84.63 a barrel (USD84.80)

(changes since previous London equities close)

----------

ECONOMICS

----------

Monday's key economic events still to come:

US Martin Luther King Day holiday. Financial markets closed.

----------

The UK foreign secretary will resume talks with his European Commission counterpart as speculation mounts that London and Brussels could be nearing a breakthrough on the Northern Ireland protocol. James Cleverly will speak to Maros Sefcovic, the commission's vice-president, on Monday over a proposal to iron out issues with post-Brexit trade arrangements affecting Northern Ireland and Great Britain. Political expectation about the prospect of an accord has grown, with suggestions that cross-Channel relations have improved since Rishi Sunak became prime minister. The announcement last week that a deal had been reached on sharing real-time data on goods travelling from Great Britain to Northern Ireland was seen as a step towards an overall resolution.

----------

BROKER RATING CHANGES

----------

Investec cuts HSBC to 'hold'

----------

Jefferies cuts abrdn to 'hold' ('buy') - price target 215 (210) pence

----------

Bofa cuts Burberry to 'underperform' ('neutral') - price target 2,000 pence

----------

COMPANIES - FTSE 100

----------

Pharmaceutical firm AstraZeneca completed its acquisition of Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacturing of T-cell receptor therapies. Neogene Therapeutics now will operate as a wholly-owned subsidiary of Astra, with operations in both Amsterdam and Santa Monica, California. AstraZeneca bought Neogene Therapeutics for an initial payment of USD200 million. It will pay an additional consideration of up to USD120 million if milestones are met.

----------

Food delivery app Just Eat announced a partnership with supermarket chain J Sainsbury for grocery delivery in the UK. The partnership will launch with more than 175 Sainsbury's stores by the end of February. As a result of the contact, Just Eat customer will have access to thousands of products, including Sainsbury's own brand products, for delivery, it says.

----------

COMPANIES - FTSE 250

----------

Asset manager Ashmore said that in the final quarter of 2022 its assets under management increased by USD1.2 billion to an estimated USD57.2 billion. At September 30, Ashmore had USD56.0 billion in AuM. Ashmore said the increase was due to a positive investment performance of USD3.8 billion, offset by net outflows of USD2.6 billion. "Reflecting a modest easing of global macro concerns, the Emerging Markets delivered strong returns over the quarter with the main fixed income and equity benchmark indices rising by between 5% and 10%. Ashmore's active investment processes delivered outperformance in the period across a broad range of fixed income and equity strategies, reflecting the typical profile of alpha creation as markets begin to recover from oversold levels," Ashmore explained.

----------

Primary care property investor Assura said it had a portfolio of 607 properties with an annualised rent roll of GBP141.6 million as of the end of 2022. It is currently on site with 11 developments which have a total cost of GBP121 million. However, Assura noted its net initial yield as of December 31 was 4.86%. It explained this represented a 7% reduction in its portfolio value which, at the end of 2022, stood at GBP2.7 billion.

----------

QinetiQ announced it has won a GBP80 million contract with the UK Ministry of Defence. The contract will provide specialist mission data and electronic warfare skills solutions, alongside training and IT support, the firm explained. QinetiQ will work with the UK MOD for a 10-year period. Chief Executive James Willis said: "The contract demonstrates how the MoD works closely with industry to build the skills of the future and introduce innovative approaches to enhance mission capability." QinetiQ is an engineering firm operating primarily in the defence and security markets.

----------

OTHER COMPANIES

----------

ITM Power said it has become clear that the outcome for the year ending April 30 will be "materially different" from current guidance, with lower revenue and a higher earnings before interest, taxation, depreciation and amortisation loss. The hydrogen-generating electrolyser system manufacturer said this conclusion came following a review of its operations after the appoint of Dennis Schulz as chief executive. The main factors hurting its outcome for the full-year are losses on customer contracts, legacy commitments for earlier product generations causing on-site support costs, warranty provisions, and inventory write-downs originating from iterations of product designs during manufacturing. ITM Power outlined a 12-month priorities plan, which will be presented in full on January 31, which aims to make ITM Power a "more focused" company. It covers three main areas: its core product portfolio, plans for future testing and automation and its approach to capital allocation and costs.

----------

NewMed Energy said it continues to promote its proposed merger with Capricorn Energy on the existing terms, saying this is the most compelling option for all stakeholders. However, NewMed also says it continues to consider alternative strategic options to the merger with Capricorn, which is facing pushback on the deal from shareholder Palliser Capital Master Fund.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.